NK cells in the brain: implications for brain tumor development and therapy

大脑发育 脑瘤 神经科学 医学 心理学 病理
作者
Agisilaos Balatsoukas,Filippo Rossignoli,Khalid Shah
出处
期刊:Trends in Molecular Medicine [Elsevier BV]
卷期号:28 (3): 194-209 被引量:16
标识
DOI:10.1016/j.molmed.2021.12.008
摘要

Natural killer (NK) cell therapies are finding their way as promising tools for more effective treatment of brain tumors. Their unique physiology makes NK cells particularly suited for this role, offering two major advantages: independence from antigen presentation by MHC molecules, and safety for allogeneic use. Advances in culturing techniques, supplying combinations of growth factors and/or engineered feeder layer cells, support vigorous NK cell expansion. These approaches offer the advantages of an off-the-shelf product, easier to genetically engineer without compromising treatment efficacy. NK cells demonstrated good safety but modest clinical activity. The concurrent application of traditional and innovative strategies, such as specific antigen targeting with chimeric antigen receptors (CARs), stimulation with activating cytokines, creation of small bispecific and trispecific killer cell engager (BiKE and TriKE) multidomain molecules, and sensitization of malignant cells through combinatorial treatments, offers new avenues to achieve better efficacy. In contrast to CAR-T cells, NK cells lend themselves to off-the-shelf applications owing to their favorable safety profile and retained efficacy in an allogeneic setting. Thus, they promise benefits in terms of treatment standardization, timeliness, and cost. Natural killer (NK) cells are innate lymphoid cells with robust antitumor functions rendering them promising therapeutic tools against malignancies. Despite constituting a minor fraction of the immune cells infiltrating tumors in the brain, insights into their role in central nervous system (CNS) pathophysiology are emerging. The challenges posed by a profoundly immunosuppressive microenvironment as well as by tumor resistance mechanisms necessitate exploring avenues to enhance the therapeutic potential of NK cells in both primary and metastatic brain malignancies. In this review, we summarize the role of NK cells in the pathogenesis of tumors in the brain and discuss the avenues investigated to harness their anticancer effects against primary and metastatic CNS tumors, including sources of therapeutic NK cells, combinations with other treatments, and novel engineering approaches for augmenting their cytotoxicity. We also highlight relevant preclinical evidence and clinical trials of NK cell-based therapies. Natural killer (NK) cells are innate lymphoid cells with robust antitumor functions rendering them promising therapeutic tools against malignancies. Despite constituting a minor fraction of the immune cells infiltrating tumors in the brain, insights into their role in central nervous system (CNS) pathophysiology are emerging. The challenges posed by a profoundly immunosuppressive microenvironment as well as by tumor resistance mechanisms necessitate exploring avenues to enhance the therapeutic potential of NK cells in both primary and metastatic brain malignancies. In this review, we summarize the role of NK cells in the pathogenesis of tumors in the brain and discuss the avenues investigated to harness their anticancer effects against primary and metastatic CNS tumors, including sources of therapeutic NK cells, combinations with other treatments, and novel engineering approaches for augmenting their cytotoxicity. We also highlight relevant preclinical evidence and clinical trials of NK cell-based therapies. a type of therapy involving the administration of immune cells to a patient. the process whereby IgG-opsonized abnormal cells undergo NK cell-mediated lysis via engagement of CD16 (FcγRIIIA) on NK cells. the central cell type of the humoral branch of the adaptive immune system whose key function is the production of antigen-specific immunoglobulins. the system composed by the microvasculature of the central nervous system that tightly regulate the movement of molecules, ions, and cells between the blood and the central nervous system. It is established by capillary endothelial cells and held together by tight junctions. small molecules designed to engage NK cells against cancer cells so that the latter undergo NK cell-mediated lysis. A BiKE consists of a tumor-associated antigen (TAA)-specific scFv coupled with an NK cell-specific scFv, while the incorporation of an additional TAA-specific scFv or a cytokine into the structure leads to the creation of a TriKE. T and NK cells engineered to express CAR molecules are referred to as CAR-T and CAR-NK cells, respectively. CAR molecules are composed of an extracellular antigen-recognizing moiety, a transmembrane domain, and an intracellular signaling region often coupled with one or two costimulatory domains. The engagement of the antigen activates the CAR-bearing immune cell against the designated target. the maintenance of the normal state of function of the central nervous system, which requires tight regulation of immune activity within its boundaries. the pathway that senses genotoxic stress and responds by arresting the cell cycle, activating DNA repair mechanisms, inducing expression of NK cell activating ligands, or initiating apoptosis. a population of glioblastoma cells that sustains tumor growth and confers resistance to conventional treatments. protein belonging to the transforming growth factor beta superfamily which exert immune evasive effects in gliomas. functional ligand for the NK cell inhibitory receptor CD161. are effector cells obtained from ex vivo culture of fresh lymphocytes in the presence of IL-2, and their cytotoxic activity is mainly mediated by the NK cell fraction of the preparation. cell surface molecules belonging to the family of major histocompatibility complex. They are present on the majority of nucleated cells and can be divided into the polymorphic, peptide-presenting classical MHC class I molecules (HLA-A, HLA-B, HLA-C) and the relatively nonpolymorphic, NK cell-regulating nonclassical MHC class I molecules (HLA-E, HLA-G). the yolk sac-derived tissue-resident macrophages of the central nervous system, in which they settle during embryonic development and constitute the predominant form of myeloid cells. immature cells of myeloid origin that are found in abnormally high frequency in the peripheral blood of patients with various pathologies, including many malignancies, and exert immunosuppressive functions in the tumor microenvironment, particularly of glioblastoma. innate lymphoid cells that patrol the organism for stressed, infected, foreign, or neoplastic cells and respond promptly with direct cytotoxicity as well as secretion of cytokines. the therapeutic administration of a virus that selectively infects and lyses malignant cells, thereby triggering a robust antitumor immune response. V-ATPase protein that regulates ATP levels in a variety of cells. the main cell type of the cell-mediated branch of the adaptive immune system. They express antigen receptors for peptides presented by MHC molecules and are traditionally divided into cytotoxic T cells (CD8+) and cytokine-producing helper T cells (CD4+). macrophages in the tumor microenvironment. In brain tumors, they are derived from microglia and circulating monocytes, and tend to exhibit an anti-inflammatory and pro-tumorigenic phenotype. the normal cells, molecules, and blood vessels that surround and support a tumor cell. A tumor influence the microenvironment, and the microenvironment can affect how a tumor grows and spreads. regulatory T cells are a specialized subpopulation of T cells that act to suppress immune response, thereby maintaining homeostasis and self-tolerance.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
橘笙发布了新的文献求助10
1秒前
Zymiao完成签到,获得积分10
2秒前
3秒前
谢敏完成签到 ,获得积分10
4秒前
5秒前
现代的卿完成签到 ,获得积分10
5秒前
LBQ完成签到,获得积分10
7秒前
7秒前
桐桐应助jianrobsim采纳,获得10
9秒前
tan90发布了新的文献求助10
12秒前
12秒前
12秒前
洁净的钢笔完成签到 ,获得积分10
14秒前
15秒前
玖玖发布了新的文献求助10
15秒前
16秒前
上官若男应助宝儿采纳,获得10
16秒前
17秒前
观zz完成签到,获得积分10
17秒前
18秒前
dddd发布了新的文献求助10
19秒前
siyu完成签到,获得积分10
19秒前
Gaoge完成签到,获得积分10
19秒前
ly发布了新的文献求助10
19秒前
20秒前
小嘉贞完成签到,获得积分10
21秒前
21秒前
BakerStreet完成签到,获得积分10
22秒前
童秋寒发布了新的文献求助30
22秒前
BakerStreet发布了新的文献求助10
25秒前
25秒前
jianrobsim发布了新的文献求助10
25秒前
26秒前
iNk应助mmyhn采纳,获得20
27秒前
慕青应助力量采纳,获得10
27秒前
27秒前
27秒前
记忆完成签到,获得积分10
28秒前
29秒前
tan90完成签到,获得积分10
29秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3969574
求助须知:如何正确求助?哪些是违规求助? 3514435
关于积分的说明 11173986
捐赠科研通 3249755
什么是DOI,文献DOI怎么找? 1794979
邀请新用户注册赠送积分活动 875537
科研通“疑难数据库(出版商)”最低求助积分说明 804844